key: cord-0940010-f4vv273j
authors: Poncin, William; Baudet, Lia; Reychler, Gregory; Duprez, Frédéric; Liistro, Giuseppe; Belkhir, Leila; Pothen, Lucie; Yildiz, Halil; Yombi, Jean-Cyr; Greef, Julien De
title: Impact of an improvised system on preserving oxygen supplies in patients with COVID-19
date: 2020-08-27
journal: Arch Bronconeumol
DOI: 10.1016/j.arbres.2020.07.019
sha: c761115c0844969cd8c552ed760729ff329b9e59
doc_id: 940010
cord_uid: f4vv273j

Patients with coronavirus disease 2019 can develop severe hypoxemia During a pandemic, oxygen demands may be high and overwhelming The double-trunk mask is an easily handmade system that can save oxygen supplies This mask safely treated hypoxemia while reducing the oxygen flow by more than 50% This mask may have clinical implications in places where oxygen supplies are limited

This ClinicalTrials.gov registered study (NCT04346420) was conducted with the approval of the local ethics committee. All subjects signed informed consent. Exclusion criteria were chronic respiratory diseases, language barriers, confusion, altered consciousness (Glasgow Coma Scale ≤12), hypoxemia corrected with oxygen flow ≤3L/min and any contra-indication to arterial puncture.

Patients were in a semi-recumbent position and received LFOT through their standard oxygen delivery method. The initial oxygen flow and delivery system were determined in accordance with our standard practice. The baseline oxygen flow was titrated to achieve a target SpO2 value of 94% at the lowest output. Oxygen flow requirements determined the baseline oxygen delivery system (supplements). The baseline delivery system was then replaced by the DTM covering nasal cannula for 30 minutes. Oxygen output (primary outcome) was adjusted to achieve the same SpO2 target as at baseline. After this period, the DTM was withdrawn and the standard oxygen delivery system was reinstated for 30 minutes. Oxygen output was readjusted to achieve the baseline SpO2 value. Patients received no instructions regarding nasal or mouth breathing during the whole process. Arterial blood gases, vital parameters and oxygen output were measured at baseline (T0) and at the end of the 30-min DTM period (T30).

Vital parameters and oxygen output were measured again 30 minutes after the DTM was withdrawn (T60). Comfort-discomfort level with each system was assessed at T30 and T60 (supplements).

Eleven subjects were needed to detect a mean difference of 2L/min 11 (SD, 1.8L/min) in oxygen output (α-risk, 0.05; power, 90%). Because SpO2 may inaccurately reflect arterial oxygen saturation (SaO2) and therefore interfere with our design, patients were retrospectively excluded from the analysis if SpO2-SaO2 mismatch exceeded the expected error of 4% 12 The DTM was also associated with a significant but slight increase in PaCO2 (median, 36 vs 37 mmHg, p=0.006), a decrease in pH (median, 7.48 vs 7.45, p=0.009) and an increase in respiratory rate (mean, 26 vs 30 breaths/min, p=0.05), Fig. 1 , e- Table 2 . Other parameters were unaltered. The DTM was generally considered less comfortable than the baseline oxygen delivery system, especially in patients requiring low oxygen flow at baseline (e- Fig. 2 ). There were no differences between T0 and T60 for any outcomes (e- Table 2 ), indicating that all values were reset when the standard delivery system was reinstated. 7 Treating hypoxemia is the cornerstone of COVID-19 patient management and this pre-post intervention trial shows that the DTM enables clinicians to safely treat severe hypoxemia while reducing the oxygen flow by more than half that required with conventional delivery systems. Therefore, settings in which oxygen supplies are limited (e.g. nursing homes, healthcare centres in deprived medical areas, during patient transport) may benefit most from the DTM.

Although evaluation of its place relative to the non-rebreathing mask, high-flow oxygen therapy or non-invasive ventilation was not within the scope of this study, we believe the DTM could also be considered when SpO2 falls below the target value with standard LFOT systems 7, 11 . Consequently, the need for non-invasive respiratory support, which increases risks of generating aerosols 6 , may possibly be avoided.

The DTM was considered less comfortable than LFOT delivered through nasal cannulas, yet patients who initially required high oxygen flow considered the DTM as equally comfortable. In conclusion, our study showed that the DTM is a useful oxygen delivery system that enables a safe reduction in oxygen output without hampering patient oxygenation. This finding is of 

Service de Médecine Interne et Maladies Infectieuses, Cliniques universitaires

Oxygen provision to fight COVID-19 in sub-Saharan Africa

Protecting healthcare workers from SARS-CoV-2 infection: practical indications

The impact of high-flow nasal cannula (HFNC) on coughing distance: implications on its use during the novel coronavirus disease outbreak

The use of high-flow nasal oxygen in COVID-19

Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group

Aerosol dispersion during various respiratory therapies: a risk assessment model of nosocomial infection to health care workers

The Double-Trunk Mask Improves Oxygenation During High-Flow Nasal Cannula Therapy for Acute Hypoxemic Respiratory Failure

Nasal dryness discomfort in individuals receiving dry oxygen via nasal cannula

Nasal mucociliary transport in healthy subjects is slower when breathing dry air

Subjective effects of humidification of oxygen for delivery by nasal cannula. A prospective study

Improvement of arterial oxygenation using the double trunk mask above low flow nasal cannula: a pilot study

Pulse oximetry: fundamentals and technology update

Accuracy of pulse oximetry in the intensive care unit